Key result
Higher early fibrinogen-to-albumin ratio linked to ~2.3-fold higher odds of poor stroke outcome.
Why the study?
Early fibrinogen-to-albumin ratio (FAR) has been linked to functional outcome after acute ischemic stroke, but reported exposure definitions and numerical scales vary across studies.
Does a higher early fibrinogen-to-albumin ratio (FAR) predict poor functional outcome in adults with acute ischemic stroke?
Meta-Analysis (n=13,253)
Yes
Does a higher early fibrinogen-to-albumin ratio (FAR) predict poor functional outcome in adults with acute ischemic stroke?
Higher early fibrinogen-to-albumin ratio is consistently associated with poor functional outcome after acute ischemic stroke in both categorical and continuous analyses, supporting its potential as a routine prognostic biomarker.
Answers are grounded in this paper and cite their sources.
Supports risk stratification after acute ischemic stroke; leaves open incremental prognostic utility beyond established markers.
Background : Early fibrinogen‐to‐albumin ratio (FAR) has been linked to functional outcome after acute ischemic stroke, but reported exposure definitions and numerical scales vary. We assessed whether higher early FAR was associated with poor functional outcome. Methods : We searched five databases through July 23, 2026 for adult acute ischemic stroke studies that measured FAR during initial assessment or before reperfusion and reported adjusted odds ratios (ORs) for modified Rankin Scale outcomes. Categorical and continuous estimates were pooled separately using restricted maximum likelihood random‐effects models with modified Hartung–Knapp confidence intervals (CIs). Continuous effects were harmonized to a common FAR_100 scale. We performed leave‐one‐out, scale‐restriction, and reperfusion analyses and assessed risk of bias with Quality In Prognosis Studies (QUIPS). The review was registered in PROSPERO (CRD420261459955). Results : Twelve studies included 13,253 participants; 12,579 contributed effect estimates. Study‐defined higher FAR was associated with poor outcome (five studies; 10,968 participants; OR, 2.32; 95% CI: 1.37–3.91; I 2 = 82.7%). Across seven continuous studies (1611 participants), each 1‐unit increase in FAR_100 was associated with poor outcome (OR, 1.30; 95% CI: 1.14–1.48; I 2 = 51.1%). Leave‐one‐out CIs remained above 1. Excluding studies requiring scale conversion produced a similar estimate (five studies; 1173 participants; OR, 1.29; 95% CI: 1.16–1.45; I 2 = 10.5%). Conclusions : Higher early FAR was associated with poor functional outcome in both categorical and continuous analyses. Prospective studies should test whether FAR adds prognostic information to established stroke models. Available evidence came from observational studies.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) conducted a meta-analysis in Acute ischemic stroke (n=13,253). Early fibrinogen-to-albumin ratio (FAR) vs. Lower study-defined FAR category (or per 1-unit increase in FAR_100 in continuous analysis) was evaluated on Poor functional outcome based on dichotomized modified Rankin Scale (mRS >2, 3-6, or 4-6) between 30 days and 1 year (OR 2.32, 95% CI 1.37-3.91). Higher early fibrinogen-to-albumin ratio was associated with poor functional outcome after acute ischemic stroke in both categorical and continuous analyses.
Synapse has enriched 10 related papers. Consider them for comparative context: